Document Detail

High-molecular-weight polyethylene glycol inhibits myocardial ischemia-reperfusion injury in vivo.
MedLine Citation:
PMID:  25455467     Owner:  NLM     Status:  Publisher    
OBJECTIVES: Cardiac ischemia-reperfusion (I-R) injury remains a significant problem as there are no therapies available to minimize the cell death that can lead to impaired function and heart failure. We have shown that high-molecular-weight polyethylene glycol (PEG) (15-20 kD) can protect cardiac myocytes in vitro from hypoxia-reoxygenation injury. In this study, we investigated the potential protective effects of PEG in vivo.
METHODS: Adult rats underwent left anterior descending artery occlusion for 60 minutes followed by 48 hours or 4 weeks of reperfusion. One milliliter of 10% PEG solution or phosphate-buffered saline (PBS) control (n = 10 per group) was administered intravenously (IV) immediately before reperfusion.
RESULTS: Fluorescein-labeled PEG was robustly visualized in the myocardium 1 hour after IV delivery. The PEG group had significant recovery of left ventricular ejection fraction at 4 weeks versus a 25% decline in the PBS group (P < .01). There was 50% less LV fibrosis in the PEG group versus PBS with smaller peri-infarct and remote territory fibrosis (P < .01). Cell survival signaling was upregulated in the PEG group with increased Akt (3-fold, P < .01) and ERK (4-fold, P < .05) phosphorylation compared to PBS controls at 48 hours. PEG also inhibited apoptosis as measured by TUNEL-positive nuclei (56% decrease, P < .02) and caspase 3 activity (55% decrease, P < .05).
CONCLUSIONS: High-molecular-weight PEG appears to have a significant protective effect from I-R injury in the heart when administered IV immediately before reperfusion. This may have important clinical translation in the setting of acute coronary revascularization and myocardial protection in cardiac surgery.
Xianyao Xu; Jennifer L Philip; Md Abdur Razzaque; James W Lloyd; Charlie M Muller; Shahab A Akhter
Related Documents :
25352047 - Longitudinal changes in resting-state brain activity in a capsular infarct model.
22279427 - An anatomy lesson and the quality of intermittence.
25436467 - Feasibility and significance of preclinical diagnosis in hypertrophic cardiomyopathy.
8443207 - Coronary artery disease after heart transplantation: timing of coronary arteriography.
17252157 - Regional cerebral oxygenation monitoring--intraoperative management in a patient with s...
1190047 - Specificity of elevated serum mb creatine phosphokinase activity in the diagnosis of ac...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-10-18
Journal Detail:
Title:  The Journal of thoracic and cardiovascular surgery     Volume:  -     ISSN:  1097-685X     ISO Abbreviation:  J. Thorac. Cardiovasc. Surg.     Publication Date:  2014 Oct 
Date Detail:
Created Date:  2014-12-2     Completed Date:  -     Revised Date:  2014-12-3    
Medline Journal Info:
Nlm Unique ID:  0376343     Medline TA:  J Thorac Cardiovasc Surg     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2014 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Embrella embolic deflection device for cerebral protection during transcatheter aortic valve replace...
Next Document:  Duplicated connective tissue growth factor genes in hypoxia-sensitive blunt snout bream Megalobrama ...